Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • BIOMARIN PHARMACEUTICAL INC Analyst Recommendations

  • Analyst Consensus: BMRN

    First Call Consensus Recommendation

    • Strong Buy1
    • Buy2
    • Hold3
    • Sell4
    • Strong Sell5
    Mean Analyst Consensus Recommendation Analysts Reporting
    Current Recommendation 1.944 Buy 18
    30 Days Ago 1.895 Buy 19
    60 Days Ago 1.944 Buy 18
    90 Days Ago 1.944 Buy 18
    120 Days Ago 2.056 Buy 18

  • Analyst Ratings: BMRN

    Brokerage Firm Previous Rating Current Rating Change Date Price Target
    Credit Suisse Neutral Outperform 10/29/2009 —
    Roth Capital Buy Hold 10/19/2009 17.00
    Jefferies & Co — Buy 10/08/2009 20.00
    Wedbush Morgan Underperform Neutral 07/31/2009 20.00
    Jefferies & Co — Buy 07/31/2009 18.00
    Roth Capital — Buy 07/27/2009 17.00
    Roth Capital — Buy 05/20/2009 18.00
    Morgan Joseph — Buy 04/21/2009 20.00
    Thomas Weisel — Market Weight 03/30/2009 14.00
    Piper Jaffray — Neutral 03/27/2009 —
    FTN Equity Capital — Buy 03/12/2009 —
    Leerink Swann — Outperform 03/12/2009 21.00
    Citigroup Hold Buy 03/03/2009 17.00
    Roth Capital Hold Buy 02/24/2009 —
    Jefferies & Co — Buy 02/23/2009 16.00
    UBS — Buy 02/19/2009 20.00
    Benchmark Buy Hold 02/19/2009 14.00
    Brean Murray — Buy 02/19/2009 20.00
    Roth Capital — Hold 02/19/2009 14.00
    Credit Suisse — Neutral 02/19/2009 19.00
    Collins Stewart Buy Hold 02/19/2009 —
    Wachovia Outperform Mkt Perform 02/19/2009 —
    Brean Murray — Buy 01/09/2009 25.00
    Benchmark Hold Buy 01/07/2009 22.00
    Stanford Research — Hold 12/23/2008 —
    Credit Suisse — Neutral 12/15/2008 23.00
    Citigroup Hold Buy 11/21/2008 22.00
    Roth Capital — Hold 10/29/2008 16.00
    Benchmark Buy Hold 10/15/2008 —
    William Blair — Outperform 09/12/2008 —
    Next